Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | METAP2 | P50579 | 3/20 | 0.41 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | MAT2A | P31153 | 9/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
| ▸ | RORC | P51449 | 1/20 | 0.33 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.32 |
| ▸ | SMO | Q99835 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21453320 | 0.91 | RORC (0.33) | CYP1A2METAP2PDE10ARORCCYP3A4 | |
| SCHEMBL21453322 | 0.88 | RORC (0.34) | MAPK14PDE10ARORC | |
| SCHEMBL21453318 | 0.84 | CYP1A2 (0.41) | CYP1A2METAP2MAPK14MAT2ACYP3A4 | |
| SCHEMBL21453324 | 0.84 | RORC (0.36) | CYP1A2MAT2ARORCCYP3A4 | |
| SCHEMBL21453321 | 0.81 | FFAR4 (0.36) | MAPK14MAT2APDE10ARORC | |
| SCHEMBL21453328 | 0.81 | PTGDR2 (0.39) | MAPK14RORC | |
| SCHEMBL1611068 | 0.80 | CYP1A2 (0.46) | CYP1A2METAP2MAPK14MAT2ACYP11B2 | |
| SCHEMBL21453323 | 0.79 | PDE10A (0.35) | CYP1A2METAP2MAT2APDE10ACYP11B2 | |
| SCHEMBL17264911 | 0.78 | CYP1A2 (0.46) | CYP1A2METAP2MAT2ACYP11B2CYP3A4 | |
| SCHEMBL21009613 | 0.78 | CYP1A2 (0.46) | CYP1A2METAP2MAPK14MAT2ACYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190312210-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, SLCO2A1, SLCO1A2 | CYP1A2 802/4885METAP2 4394/4885MAPK14 2635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.